Welcome to our dedicated page for Bio-Key Intl news (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on Bio-Key Intl stock.
BIO-key International Inc (BKYI) delivers innovative biometric authentication solutions for enterprise security and identity management. This dedicated news hub provides investors and industry professionals with complete access to official company announcements and verified developments.
Track all critical updates including earnings disclosures, product launches, strategic partnerships, and regulatory filings. Our curated collection ensures efficient monitoring of BKYI's advancements in fingerprint biometrics, identity-as-a-service platforms, and cybersecurity innovations.
Discover updates on key operational areas: deployment of PortalGuard® identity solutions, government sector contracts, and advancements in passwordless authentication technology. Content is rigorously verified to support informed decision-making in the biometrics and cybersecurity markets.
Bookmark this page for streamlined access to BIO-key's latest milestones. Check regularly for authoritative updates on one of the biometric industry's most dynamic providers of hardware and software authentication solutions.
BIO-key International, Inc. (NASDAQ: BKYI) issued a statement addressing an inaccurate third-party press release regarding one of its partners, which has been removed. The company warns investors against relying on unverified information and commits to protecting its reputation and interests. BIO-key emphasizes its innovative identity and access management solutions powered by biometrics, which secure access to various platforms. The company is dedicated to safeguarding its economic opportunities following this incident.
BIO-key International (NASDAQ: BKYI) has appointed Kimberly Johnson as the new Vice-President of Product Marketing. Johnson will oversee product marketing strategies and execution, aiming to enhance the growth of the BIO-key PortalGuard IAM solution. With previous experience at GlobalSign, Imprivata, and BitSight, Johnson's expertise in IAM marketing is expected to significantly benefit the company. CEO Michael DePasquale highlighted her role in leading growth efforts for their biometrics products as they explore new markets.
BIO-key International (NASDAQ: BKYI) announced partnerships with three educational institutions to implement their PortalGuard identity and access management solution integrated with Campus.app. This collaboration aims to provide students with secure single-sign-on (SSO) capabilities, password management, and an enhanced digital campus experience, addressing challenges posed by remote learning during the pandemic. The solution is designed for ease of use and administration, enhancing security while improving user accessibility for educational software and resources.
BIO-key International, Inc. (BKYI) reported Q2 2020 results, with revenues declining to $307,000 from $728,000 in Q2 2019, heavily impacted by COVID-19. The company completed a $2.5M acquisition of PistolStar and a $24.8M public offering, enhancing its financial position. Operating losses increased to $1.4M, while gross margin improved to 52% due to the elimination of certain expenses. Despite short-term challenges, BIO-key is optimistic about future opportunities in Africa, despite delays in contracts worth $75M.
BIO-key International (NASDAQ: BKYI) has announced a conference call on August 14, 2020, at 10 a.m. ET to discuss its second quarter 2020 results. The results will be released before market opening. Company executives, including CEO Mike DePasquale and CFO Cecilia Welch, will participate in the call. The event will be accessible via dial-in or a live webcast, which will also have a replay option available for three months. BIO-key specializes in identity and access management, providing innovative biometric solutions.
BIO-key International (NASDAQ: BKYI) announced that Clearent, a rapidly growing credit card processing company, has adopted BIO-key’s PortalGuard IAM solution to enhance security in customer self-enrollment and account recovery for its banking applications. Clearent processes $14 billion annually for over 45,000 merchants, and selected PortalGuard for its advanced transaction security and cost-effective licensing. CEO Mike DePasquale highlighted the balance between security and user experience, emphasizing the robust multifactor authentication options included in PortalGuard.
BIO-key International (NASDAQ: BKYI) has secured a contract with the municipality of Durham, North Carolina, to implement its PortalGuard solution for identity and access management (IAM) and cybersecurity. This decision follows a thorough review of potential solutions, aimed at enhancing security against growing cyber threats. PortalGuard will provide self-service password management and integration with Office 365 and Active Directory, facilitating secure access across the city’s enterprise applications.
BIO-key International (NASDAQ: BKYI) announced that Fore Aero, a manufacturer for national defense, selected its PortalGuard IAM platform for secure authentication. The decision stemmed from PortalGuard's security, flexibility, and cost-effectiveness. As a government contractor, Fore Aero required a multifactor authentication solution for Windows 10 workstations and environments lacking internet access, which eliminated other vendor options. PortalGuard supports various authentication methods, ensuring compliance and security for Fore Aero's operations.
BIO-key International (NASDAQ: BKYI) has successfully completed an underwritten public offering of 38,214,500 shares of common stock and warrants, generating approximately $24.8 million in gross proceeds. Each share or pre-funded warrant was sold for $0.65, paired with a warrant to purchase an additional share at the same price, expiring in five years. The offering was managed by Maxim Group LLC, with the registration statements filed with the SEC. This capital influx supports BIO-key's biometric security solutions and potential market expansion.
BIO-key International, Inc. (BKYI) announced the pricing of an underwritten public offering of 33,230,000 shares of common stock combined with common warrants, with gross proceeds estimated at $21.6 million before expenses. Each share is priced at $0.65, and the offering is expected to close around July 23, 2020, subject to customary conditions. Additionally, the underwriter has a 45-day option to purchase 4,984,500 more shares and warrants. This offering aims to bolster the company’s financial position in the biometric authentication sector.
